ot ii peptide both specific for a C-terminal epitope - Ovapeptide self Ea peptide

Ot1 mice The ot ii peptide is a crucial tool in immunological research, specifically for studying T cell responses.It is a highly immunogenic protein and can be used forpeptideconjugation in the development of antibodies. OVAPeptide(323-339). Code: POV-3636-PI. This peptide, derived from ovalbumin (OVA), is recognized by a genetically engineered T cell receptor (TCR) found in OT-II miceThe Y-Ae antibody reacts with a class II major histocompatibility complex (MHC)self Ea peptide(peptide 52-68) bound to I-Ab molecules.. These mice are transgenic, meaning they express a specific TCR that pairs with the CD4 co-receptor, making them ideal for investigating antigen-specific CD4 T cell responses. The primary function of the ot ii peptide is to activate these specific T cells, enabling researchers to understand T cell activation pathways, immune regulation, and the development of immunological memory.OT-II cells activation : r/Immunology

Understanding the OT-II Peptide and its Role in Immunology

The OT-II T cell receptor (TCR) is engineered to recognize a specific epitope of ovalbumin (OVA)IA b OVA 323-339 Tetramer (Code No. TS-M710-1)can be used to monitor antigen-specific CD4 T cell responses in OT-II miceand in various experimental systems.. This epitope is typically the sequence OVA 323-339, which binds to the MHC class II molecule I-A^b. When this peptide-MHC complex is presented to T cells expressing the OT-II TCR, it triggers a robust immune responseOvalbumin - an overview | ScienceDirect Topics. This interaction is fundamental for studying CD4+ T helper cell function, as the OT-II TCR is specifically designed to engage with this particular peptide presented by MHC class II molecules作者：JM Robertson·2000·被引用次数：478—DO11.10 and OT-II T cells areboth specific for a C-terminal epitopewhose core encompasses amino acids 329-337..

Researchers utilize the ot ii peptide in various experimental settings. For instance, it's commonly used to stimulate splenocytes or isolated CD4+ T cells from OT-II miceOVA peptide 323-339represents a T and B cell epitope of OVA, which is important in the generation and development of immediate hypersensitivity responses .... This activation process allows for the examination of cytokine production, proliferation, and other effector functions of these antigen-specific T cells. The peptide can also be presented by antigen-presenting cells (APCs), such as dendritic cells, which then activate the OT-II T cells. This approach is vital for dissecting the intricate mechanisms of T cell-APC interactions and immune cell signaling.

Key Applications and Experimental Systems

The OT-II model, in conjunction with the ot ii peptide, offers a powerful system for exploring a wide range of immunological phenomena. Beyond basic T cell activation, these tools are instrumental in:

* Vaccine Development: Understanding how T cells respond to specific antigens is critical for designing effective vaccines.作者：JM Kel·2008·被引用次数：22—Abstract. In this study, we investigated the development of T cell responses in mice after administration of a mannosylated ovalbuminpeptide(M-OVA323–339. The OT-II system can be used to evaluate vaccine candidates designed to elicit CD4+ T cell immunity. Researchers can assess the immunogenicity of novel peptide-based vaccines or vaccine delivery systems by measuring OT-II T cell responses.OT II Mouse - Charles River Laboratories

* Autoimmunity and Tolerance: By studying how OT-II T cells interact with self-peptides or modified OVA peptides, researchers can gain insights into the mechanisms that lead to autoimmune diseases or the development of immune tolerance.

* Immunomodulation: The OT-II system allows for the investigation of molecules and pathways that can either enhance or suppress T cell activity.004194 - OT-II Strain Details This is crucial for developing immunotherapies for conditions like cancer or autoimmune disorders. For example, studies have explored how certain receptors or signaling molecules affect OT-II T cell activation and function.

* T Cell Migration and Trafficking: Researchers can track the movement and behavior of antigen-specific T cells in vivo using OT-II mice, often by employing labeled peptides or tetramers. This helps in understanding how immune cells navigate the body and reach sites of inflammation or infection.

Variations and Considerations in Peptide Usage

While OVA 323-339 is a widely used sequence, variations and related peptides exist. Some research uses slightly different lengths or modifications of the ovalbumin peptide作者：CLV Westhorpe·2018·被引用次数：72—We have previously shown thatOT-IIcells can trigger antigen-dependent neutrophil recruitment within 4 h in a planted antigen model of CD4+T- .... For instance, the sequence OVA (329-337) is also mentioned in some contexts, and tetramers based on shorter versions of the epitope, like OVA 329-337, have been developed for improved staining of OT-II cells. The choice of peptide sequence can sometimes influence the strength and specificity of the T cell response.

It's also important to consider the context in which the peptide is presented. The ot ii peptide is recognized in the context of specific MHC class II molecules, primarily I-A^b. Therefore, experiments involving OT-II T cells typically require cell lines or animal models expressing the appropriate MHC background. Additionally, factors like peptide concentration, presence of co-stimulatory signals, and the quality of antigen-presenting cells can significantly impact T cell activation outcomes. Researchers often use purified peptides, sometimes in salt forms like TFA salt, to ensure purity and consistency in their experimentsThromboxane A2 acts as tonic immunoregulator by ....

In conclusion, the ot ii peptide is an indispensable reagent for immunologists. Its ability to specifically activate engineered T cells in OT-II mice provides a well-defined model for dissecting complex immunological processes, driving advancements in our understanding of adaptive immunity and informing the development of novel therapeutic strategies.作者：A Sexton·2009·被引用次数：196—Thesepeptidescan bind directly to MHC-I/II on the cell surface with- out the requirement for antigen processing to activate. OT-I CD8 andOT-IICD4 T cells.